- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06807047
Effect of the EpiSchool-M App on Teachers' Epilepsy Knowledge, Attitudes, and Self-Management (EpiSchool-M)
The Effect of Epilepsy Management at School Mobile Health Application on Epilepsy Knowledge, Attitudes, and Self-Management of Teachers of Children With Intellectual Disability: A Randomized Controlled Study
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Konyaaltı
-
Antalya, Konyaaltı, Turkey, 07070
- Akdeniz University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Working at special education schools affiliated with the Ministry of National Education in Antalya Province,
- Teachers of children with moderate to severe intellectual disabilities,
- Having a smartphone with internet access and either an Android or iOS operating system.
Exclusion Criteria:
- Teachers of children with hearing and visual impairments, without intellectual disabilities
- Teachers of children with mild intellectual disabilities
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Mobile Application Group
Teachers in the Epilepsy Management at School Mobile Health Application group will download the EpiSchool app to their phones.
Within two weeks, they will watch the epilepsy-related educational videos and the animation video integrated into the app.
|
Teachers who meet the inclusion criteria will use the EpiSchool
|
|
Experimental: Digital Education Guide Group
The digital guide, prepared based on expert opinions, will be sent to the teachers via a link.
They will be asked to read the guide within 15 days.
|
Teachers who meet the inclusion criteria will use the EpiGuide
|
|
No Intervention: Control Group
Group without any intervention
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Knowledge And Attitudes Toward Epilepsy Among School Teachers Scale
Time Frame: 1.5 months
|
The scales developed by Kos et al. (2023) assess knowledge and attitudes toward epilepsy. A higher total score indicates a higher level of knowledge and attitude. The scales consist of two parts: the "Attitudes Toward Epilepsy Among School Teachers Scale" and the "Knowledge Toward Epilepsy Among School Teachers Scale." The "Attitudes Toward Epilepsy Among School Teachers Scale" has two subdimensions: attitudes toward social relationships of children with epilepsy (10 items) and attitudes toward epilepsy-related limitations (5 items), totaling 15 items. A lower score on this scale indicates more positive attitudes toward epilepsy. The "Knowledge Toward Epilepsy Among School Teachers Scale" includes two subdimensions: knowledge about epilepsy (2 items) and knowledge about epilepsy's effects (10 items), totaling 12 items. A lower score on this scale indicates higher knowledge about epilepsy. Both scales are five-point Likert-type measurement tools. |
1.5 months
|
|
Epilepsy Self-Management Scale for Teachers
Time Frame: 1.5 months
|
The Epilepsy Self-Management Scale for Teachers, developed by Kos et al. (2022), aims to assess epilepsy self-management in teachers.
It is a 23-item, five-point Likert scale.
Responses are numbered from 1 to 5, with 1 meaning "Never" and 5 meaning "Always."
Each item on the scale can receive a score between 1 and 5.
The scale consists of three subdimensions: the first subdimension is seizure-related self-management (13 items), the second subdimension is pre-seizure self-management (5 items), and the third subdimension is post-seizure self-management (5 items).
|
1.5 months
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- KAEK-33
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Epilepsy
-
NaviFUS CorporationTaipei Veterans General Hospital, TaiwanCompletedDrug Resistant Epilepsy | Epilepsy, Drug Resistant | Intractable Epilepsy | Refractory Epilepsy | Drug Refractory Epilepsy | Epilepsy, Drug Refractory | Epilepsy, Intractable | Medication Resistant EpilepsyTaiwan
-
Great Ormond Street Hospital for Children NHS Foundation...Active, not recruitingEpilepsies, Partial | Intractable Epilepsy | Focal Epilepsy | Refractory Epilepsy | Epilepsy Intractable | Epilepsy in Children | Epilepsy, FocalUnited Kingdom
-
University of British ColumbiaTerminatedJuvenile Myoclonic Epilepsy | Childhood Absence Epilepsy | Juvenile Absence EpilepsyCanada
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruiting
-
Oslo University HospitalCompletedEpilepsy | Generalized Epilepsy | Focal EpilepsyNorway
-
UCB Pharma SACompletedEpilepsy, Tonic-clonicPoland, Sweden, Hungary, Czechia
-
UCB PharmaCompletedEpilepsy, Tonic-clonic
-
Institute of Child HealthGreat Ormond Street Hospital for Children NHS Foundation TrustNot yet recruitingEpilepsy Intractable | Epilepsy in Children
-
University Hospital, LilleCompletedFocal Epilepsy | Epilepsy IntractableFrance
-
Massachusetts General HospitalBoston University; National Institute of Neurological Disorders and Stroke...CompletedEpilepsy | Epilepsy; Seizure | Rolandic Epilepsy | Rolandic Epilepsy, Benign | Centrotemporal Epilepsy | Centrotemporal; EEG Spikes, Epilepsy of ChildhoodUnited States
Clinical Trials on Epilepsy Management at School Mobile Health Application
-
Diakonhjemmet HospitalThe Dam Foundation; The Norwegian Council for Musculoskeletal HealthActive, not recruiting
-
Chinese University of Hong KongRecruitingOncology | SurvivorshipHong Kong
-
Mohd Khairul Zul Hasymi FirdausPrince of Songkla UniversityCompletedDiabetes Mellitus, Type 2Malaysia
-
Sevda DemirelGGZ CentraalCompletedWork-Related Stress | Coping Behaviour | User Experience of Mobile ApplicationNetherlands
-
Chinese University of Hong KongCompletedOncology | SurvivorshipHong Kong
-
ElsanNot yet recruiting
-
San Diego State UniversityRecruitingObesity | Diabetes Mellitus, Type 2United States
-
University of CadizCompleted
-
Saglik Bilimleri UniversitesiGümüşhane UniversıtyNot yet recruitingMobile Application | End-Stage Renal Disease Requiring HaemodialysisTurkey (Türkiye)
-
San Diego State UniversityRecruitingObesity | Diabetes Mellitus, Type 2United States